110 related articles for article (PubMed ID: 27704873)
1. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21.
Zhang L; He S; Yang F; Yu H; Xie W; Dai Q; Zhang D; Liu X; Zhou S; Zhang K
Can J Physiol Pharmacol; 2016 Dec; 94(12):1249-1256. PubMed ID: 27704873
[TBL] [Abstract][Full Text] [Related]
2. Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499-5p/APC axis.
Zhou J; Zhang S; Sun X; Lou Y; Bao J; Yu J
J Pharmacol Sci; 2021 May; 146(1):10-20. PubMed ID: 33858650
[TBL] [Abstract][Full Text] [Related]
3. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
[TBL] [Abstract][Full Text] [Related]
5. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice.
Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X
Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810
[TBL] [Abstract][Full Text] [Related]
6. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
7. Protective role of oryeongsan against renal inflammation and glomerulosclerosis in db/db mice.
Yoon JJ; Lee YJ; Kang DG; Lee HS
Am J Chin Med; 2014; 42(6):1431-52. PubMed ID: 25482677
[TBL] [Abstract][Full Text] [Related]
8. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice.
Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785
[TBL] [Abstract][Full Text] [Related]
10. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
11. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
[TBL] [Abstract][Full Text] [Related]
12. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.
Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J
J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556
[TBL] [Abstract][Full Text] [Related]
14. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
15. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
17. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy.
Ma W; Wang KJ; Cheng CS; Yan GQ; Lu WL; Ge JF; Cheng YX; Li N
J Ethnopharmacol; 2014 May; 153(3):840-5. PubMed ID: 24694395
[TBL] [Abstract][Full Text] [Related]
18. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.
Zhang Z; Peng H; Chen J; Chen X; Han F; Xu X; He X; Yan N
FEBS Lett; 2009 Jun; 583(12):2009-14. PubMed ID: 19450585
[TBL] [Abstract][Full Text] [Related]
20. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats].
Duan HJ; Liu SX; Zhang YJ; Liu QJ; He N; Li YM
Yao Xue Xue Bao; 2004 Jul; 39(7):481-5. PubMed ID: 15493832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]